xCures has announced it is partnering with CancerCompass to allow consumers who contact CancerCompass to access the xCures’ platform and services. xCures’ comprehensive cancer case review service includes a high-quality Cancer Journey patient summary created by the xCures team that organizes and summarizes a patient’s medical records. These summaries are reviewed by xCures’ clinical scientists to identify appropriate treatment possibilities, which could include a highly curated set of novel therapies and multi-drug combinations vetted by leading oncologists and cancer scientists. xCures then provides patients with a summary report that they can share with their oncologists and health-care providers. The report includes a list of top options, the rationale supporting each recommendation and how to access the options. xCures even assists patients in accessing their preferred options. That assistance could include contacting clinical trial sites, obtaining investigational therapies through managed access and compassionate use programs, and petitioning for insurance coverage for off-label use of approved drugs. “xCures partnering with CancerCompass is a significant step toward improving access to personalized knowledge about advanced cancer treatment options,” said xCures CEO Mika Newton in the press release. “This is important progress in our mission to broaden the availability of our comprehensive cancer case review services, positively affecting the largest number of cancer patients and their physicians.”
To view the full press release, visit https://www.nnw.fm/QomoL
About xCures Inc.
xCures operates an AI-assisted platform that connects cancer patients and physicians with optimal investigational or approved therapies. The platform prospectively generates real-world evidence for clinical studies and decentralized trials. For more information about the company, please visit www.xCures.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
